Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study

Chemotherapy-induced neutropenia (CIN) is one of the major adverse events that necessitate chemotherapy dose reduction. This study aimed to evaluate the association between grade 4 neutropenia and genetic polymorphisms in breast cancer patients. In this genetic polymorphism association study, periph...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Daiki, Ikeda, Midori, Yamamoto, Keisuke, Nakamori, Harumi, Kim, Yong-Il, Kawasaki, Yohei, Otake, Aki, Yokoi, Mari, Inoue, Kazuyuki, Hirai, Keita, Nakamichi, Hidenori, Tokou, Umi, Shiokawa, Mitsuru, Itoh, Kunihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591095/
https://www.ncbi.nlm.nih.gov/pubmed/27858847
http://dx.doi.org/10.1097/MD.0000000000005151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591095/
https://www.ncbi.nlm.nih.gov/pubmed/27858847
http://dx.doi.org/10.1097/MD.0000000000005151

Ejemplares similares